USA: Florida recommends against males aged 18 to 39 receiving mRNA COVID-19 vaccines

Coronavirus, Florida, Health, Healthcare, Moderna, Pfizer/Biontech, Research, Side Effects, Symptoms, USA, Vaccine

“The State Surgeon General recommends against males aged 18 to 39 from receiving mRNA COVID-19 vaccines.”.

Today, State Surgeon General Dr. Joseph A. Ladapo has announced new guidance regarding mRNA vaccines. The Florida Department of Health (Department) conducted an analysis through a self-controlled case series, which is a technique originally developed to evaluate vaccine safety.

This analysis found that there is an 84% increase in the relative incidence of cardiac-related death among males 18-39 years old within 28 days following mRNA vaccination. With a high level of global immunity to COVID-19, the benefit of vaccination is likely outweighed by this abnormally high risk of cardiac-related death among men in this age group. Non-mRNA vaccines were not found to have these increased risks.

As such, the State Surgeon General recommends against males aged 18 to 39 from receiving mRNA COVID-19 vaccines. Those with preexisting cardiac conditions, such as myocarditis and pericarditis, should take particular caution when making this decision.

“Studying the safety and efficacy of any medications, including vaccines, is an important component of public health,” said Surgeon General Dr. Joseph Ladapo. “Far less attention has been paid to safety and the concerns of many individuals have been dismissed – these are important findings that should be communicated to Floridians.”

The analysis can be found here. The guidance can be found here.








Dr Deepti Gurdasani has taken a look at the science behind Florida’s decision:


The vaccine injured have their say. Please listen without prejudice:




Preprint: Nuclear translocation of spike mRNA and protein is a novel pathogenic feature of SARS-CoV-2


Follow Coronaheadsup on Twitter for our latest updates


H/t Zerohedge

Image by Pexels from Pixabay

** This post was originally published on October 8, 2022 **